Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- asymptomatic
Otros factores de diagnóstico
- cervical discharge
- friable cervix
- abnormal vaginal bleeding
- penile discharge
- vaginal discharge
- dysuria
- pelvic pain
- fever/chills
- nausea/vomiting
- scrotal pain
- myalgias
- abdominal pain
- mucopurulent rectal discharge or tenesmus
- joint pain and swelling
- eye irritation
- rashes
- inflammation
Factores de riesgo
- age under 25 years, sexually active
- new sex partner or multiple sex partners
- sexual activity with infected partner
- condoms not used
- history of prior STI
- ethnicity
- urban residence and low socioeconomic status
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- nucleic acid amplification test (NAAT)
Pruebas diagnósticas que deben considerarse
- direct immunofluorescence
- enzyme immunoassay
- nucleic acid hybridization tests
- cell culture
Pruebas emergentes
- rapid and point-of-care tests
Algoritmo de tratamiento
confirmed or suspected
Colaboradores
Autores
Matthew M. Hamill, MBChB, PhD, FRCP
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore
MD
Divulgaciones
MMH receives royalties for contributing to UpToDate on Lymphogranuloma venereum and for Clinical Care Options. He has an honorarium from Roche Diagnostics for panel STI & HIV 2021 World Congress (virtual) and was a member of the 2021 Roche group on future of POCT for STI. He has also received consulting fees from GSK for the HSV vaccine.
Agradecimientos
Dr Matthew M. Hamill would like to gratefully acknowledge Dr Anne Rompalo and Dr Christopher K. Fairley, the previous contributors to this topic.
Divulgaciones
AR and CKF declare that they have no competing interests.
Revisores por pares
Kenneth Lin, MD
Assistant Editor
American Family Physician
Clinical Assistant Professor
GUSOM Medical Officer
US Preventive Services Task Force
Divulgaciones
KL declares that he has no competing interests.
Lars Jørgen Østergaard, MD, PhD, DMSc
Professor/Head
Department of Infectious Diseases
Aarhus University Hospital
Skejby Sygehus
Aarhus
Denmark
Divulgaciones
LJO has been funded by Pfizer to write a leaflet on Chlamydia infections.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Texto completo Resumen
Centers for Disease Control and Prevention. Sexually transmitted infections surveillance, 2023. Nov 2024 [internet publication].Texto completo
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo Resumen
US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Texto completo
Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Texto completo Resumen
American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Lymphogranuloma venereum
- Gonorrhea infection
- Bacterial vaginosis
Más DiferencialesGuías de práctica clínica
- 2025 European guideline on the management of Chlamydia trachomatis infections
- Reducing sexually transmitted infections
Más Guías de práctica clínicaFolletos para el paciente
Chlamydia
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad